This study looks at how well a new drug called Elismetrep (K-304) works to treat migraines, which are bad headaches. It's a double-blind study, meaning neither you nor the researchers will know if you're getting the real drug or a placebo (a harmless pill). It will happen in multiple places, and you don't have to stay overnight.

Key Points:

• The study is for adults aged 18 to 75 with a history of migraines.
• You must have 2 to 10 migraine attacks per month to join.
• You need to agree to use a smartphone app to track migraines.

You can't join if you're pregnant, have certain types of headaches, or have other health issues like heart disease or drug abuse history. If you're chosen, you'll help researchers learn if Elismetrep can help people with migraines.